Search details
1.
Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation.
Cancer
; 127(23): 4339-4347, 2021 Dec 01.
Article
in English
| MEDLINE | ID: mdl-34375439
2.
High risk of relapse with intermediate dose cytarabine for consolidation in young favourable-risk acute myeloid leukaemia patients following induction with 7+3: a retrospective multicentre analysis and critical review of the literature.
Br J Haematol
; 194(1): 140-144, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33843048
3.
Risk factors for de novo and therapy-related myelodysplastic syndromes (MDS).
Cancer Causes Control
; 32(3): 241-250, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33392905
4.
Myeloablative versus Reduced-Intensity Hematopoietic Cell Transplantation in Myelodysplastic Syndromes: Systematic Review and Meta-analysis.
Biol Blood Marrow Transplant
; 26(6): e138-e141, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32171885
5.
Use of Potentially Inappropriate Medications in Older Allogeneic Hematopoietic Cell Transplantation Recipients.
Biol Blood Marrow Transplant
; 26(12): 2329-2334, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32919078
6.
Surveillance Imaging after Autologous Hematopoietic Cell Transplantation Predicts Survival in Patients with Diffuse Large B Cell Lymphoma.
Biol Blood Marrow Transplant
; 26(2): 272-277, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31669174
7.
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 26(11): 2139-2146, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32781289
8.
Alcohol use is not a significant contributor to myelodysplastic syndromes.
Cancer Causes Control
; 31(6): 549-557, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32285234
9.
Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up.
Biol Blood Marrow Transplant
; 25(1): 56-62, 2019 01.
Article
in English
| MEDLINE | ID: mdl-30077015
10.
Hematopoietic Cell Transplant-Related Toxicities and Mortality in Frail Recipients.
Biol Blood Marrow Transplant
; 25(12): 2454-2460, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31394273
11.
Factors predicting early mortality after new diagnosis of myelodysplastic syndrome: A population-based study.
Eur J Haematol
; 103(1): 56-63, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31058390
12.
Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics.
Haematologica
; 103(12): 2109-2115, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30076172
13.
Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect.
Am J Hematol
; 2018 May 14.
Article
in English
| MEDLINE | ID: mdl-29756385
14.
Multiple transmissions of chromosomally integrated human herpesvirus-6 in one family.
Transpl Infect Dis
; 20(1)2018 Feb.
Article
in English
| MEDLINE | ID: mdl-29156094
15.
Chemical exposures and risk of acute myeloid leukemia and myelodysplastic syndromes in a population-based study.
Int J Cancer
; 140(1): 23-33, 2017 Jan 01.
Article
in English
| MEDLINE | ID: mdl-27603749
16.
Allogeneic Hematopoietic Cell Transplantation for Older Patients: Prognosis Determined by Disease Risk Index.
Biol Blood Marrow Transplant
; 23(9): 1485-1490, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28522345
17.
Matching at Human Leukocyte Antigen-C Improved the Outcomes after Double Umbilical Cord Blood Transplantation for Recipients of Two to Four of Six Human Leukocyte Antigen-Matched Grafts.
Biol Blood Marrow Transplant
; 23(1): 126-133, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27989929
18.
Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 23(6): 971-979, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-28288952
19.
History of consolidation is prognostic in acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation in minimal residual disease-negative first complete remission.
Am J Hematol
; 92(10): 1032-1036, 2017 Oct.
Article
in English
| MEDLINE | ID: mdl-28646534
20.
Impending relapse of myelodysplastic syndrome after allogeneic transplant is difficult to diagnose and requires a multi-modal approach.
BMC Clin Pathol
; 17: 28, 2017.
Article
in English
| MEDLINE | ID: mdl-29299024